GITR ligand fusion protein agonist enhances the tumor antigen–specific CD8 T-cell response and leads to long-lasting memory
Nick M. Durham, Nick Holoweckyj, Randall S. MacGill, Kelly McGlinchey, Ching Ching Leow, Scott H. Robbins
Journal for ImmunoTherapy of Cancer Dec 2017, 5 (1) 47; DOI: 10.1186/s40425-017-0247-0